Hiroko Tsunekawa

562 total citations
13 papers, 496 citations indexed

About

Hiroko Tsunekawa is a scholar working on Cellular and Molecular Neuroscience, Neurology and Cognitive Neuroscience. According to data from OpenAlex, Hiroko Tsunekawa has authored 13 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 4 papers in Neurology and 3 papers in Cognitive Neuroscience. Recurrent topics in Hiroko Tsunekawa's work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Hiroko Tsunekawa is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Hiroko Tsunekawa collaborates with scholars based in Japan, United States and South Korea. Hiroko Tsunekawa's co-authors include Toshitaka Nabeshima, Yukihiro Noda, Akihiro Mouri, Fumio Yoneda, Dayong Wang, Masayuki Miyazaki, Kazue Takahata, Hyoung‐Chun Kim, Satoshi Tanaka and Kazuhito Tsuboi and has published in prestigious journals such as Journal of Neuroscience, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Hiroko Tsunekawa

13 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Tsunekawa Japan 11 153 143 135 110 60 13 496
Roberta Facchinetti Italy 13 117 0.8× 158 1.1× 103 0.8× 127 1.2× 125 2.1× 15 481
Cristiane Batassini Brazil 13 112 0.7× 145 1.0× 126 0.9× 52 0.5× 95 1.6× 17 477
И. А. Гривенников Russia 15 232 1.5× 163 1.1× 274 2.0× 39 0.4× 59 1.0× 82 648
Pooneh Memar Ardestani United States 9 158 1.0× 113 0.8× 211 1.6× 40 0.4× 95 1.6× 16 483
Shunji Yamashita Japan 10 254 1.7× 297 2.1× 232 1.7× 83 0.8× 80 1.3× 11 576
Maria Cristina Marrone Italy 10 175 1.1× 141 1.0× 185 1.4× 92 0.8× 203 3.4× 10 619
S. Croes Belgium 7 266 1.7× 422 3.0× 244 1.8× 159 1.4× 88 1.5× 9 658
E. Dobó Hungary 11 227 1.5× 108 0.8× 161 1.2× 32 0.3× 46 0.8× 21 433
Cornelia Dorner‐Ciossek Germany 19 220 1.4× 176 1.2× 412 3.1× 205 1.9× 76 1.3× 41 817
Zsuzsa Penke Hungary 11 139 0.9× 172 1.2× 152 1.1× 32 0.3× 76 1.3× 12 532

Countries citing papers authored by Hiroko Tsunekawa

Since Specialization
Citations

This map shows the geographic impact of Hiroko Tsunekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Tsunekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Tsunekawa more than expected).

Fields of papers citing papers by Hiroko Tsunekawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Tsunekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Tsunekawa. The network helps show where Hiroko Tsunekawa may publish in the future.

Co-authorship network of co-authors of Hiroko Tsunekawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Tsunekawa. A scholar is included among the top collaborators of Hiroko Tsunekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Tsunekawa. Hiroko Tsunekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nakamura, Yoshitsugu, Shigeki Arawaka, Hiroyasu Sato, et al.. (2021). Monoamine oxidase-B inhibition facilitates α-synuclein secretion in vitro and delays its aggregation in rAAV-based rat models of Parkinson’s disease. Journal of Neuroscience. 41(35). JN–RM. 12 indexed citations
3.
Tsunekawa, Hiroko, et al.. (2018). Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity. Behavioural Brain Research. 359. 353–361. 21 indexed citations
4.
Mizoguchi, Hiroyuki, Kazuhiro Takuma, Daisuke Ibi, et al.. (2009). Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice. Journal of Pharmacology and Experimental Therapeutics. 331(1). 14–22. 74 indexed citations
5.
Tsunekawa, Hiroko, Yukihiro Noda, Akihiro Mouri, Fumio Yoneda, & Toshitaka Nabeshima. (2008). Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35). Behavioural Brain Research. 190(2). 224–232. 78 indexed citations
6.
Tsunekawa, Hiroko, et al.. (2008). Effects of (R)-(−)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(−)-BPAP] in animal models of mood disorders. Behavioural Brain Research. 189(1). 107–116. 12 indexed citations
7.
Amino, Takeshi, Toshiki Uchihara, Hiroko Tsunekawa, et al.. (2007). Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction. Neuroscience Research. 60(3). 314–318. 16 indexed citations
8.
Wang, Dayong, Yukihiro Noda, Hiroko Tsunekawa, et al.. (2007). Role of N-Methyl-D-aspartate Receptors in Antidepressant-Like Effects of σ1 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine Dihydrochloride (SA-4503) in Olfactory Bulbectomized Rats. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1305–1314. 22 indexed citations
9.
Wang, Dayong, et al.. (2007). Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behavioural Brain Research. 178(2). 262–273. 78 indexed citations
10.
Yamaguchi, Yoshimasa, Hiroko Tsunekawa, Akihiro Mouri, et al.. (2006). Effects of a Novel Cognitive Enhancer, Spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3 H)-one (ZSET1446), on Learning Impairments Induced by Amyloid-β1–40 in the Rat. Journal of Pharmacology and Experimental Therapeutics. 317(3). 1079–1087. 68 indexed citations
11.
Segi‐Nishida, Eri, Yukihiko Sugimoto, Masayuki Tsuji, et al.. (2003). Expression of Messenger RNA for Prostaglandin E Receptor Subtypes EP4/EP2 and Cyclooxygenase Isozymes in Mouse Periovulatory Follicles and Oviducts During Superovulation1. Biology of Reproduction. 68(3). 804–811. 69 indexed citations
12.
Shimazu, Seiichiro, Hiroko Tsunekawa, Fumio Yoneda, et al.. (2003). Transporter-mediated actions of R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane. European Journal of Pharmacology. 482(1-3). 9–16. 9 indexed citations
13.
Shimazu, Seiichiro, Kazue Takahata, Hiroshi Katsuki, et al.. (2001). (−)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release. European Journal of Pharmacology. 421(3). 181–189. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026